Acquired Varian for $16.4 billion in early 2021
Cost analysis favorably compares proton APBI with radiation WBI
28th PT center in the U.S.
Research funded by feds to save lives offers faster, cheaper testing
First European installation to be in Netherlands
New paper offers tips for balancing benefits and risks without stirring up radiophobia
Will add BNCT as a radiotherapy modality through alliance with Neutron Therapeutics
$190 million and 12 years in the making
Q&A with ASTRO president Dr. Laura Dawson
The first proton therapy center in the Hainan province
Integrating Hermia dosimetry products into the syngo.via imaging platform
The biggest MR stories of the year from our Daily News online
Staff will bring together 70 years' net worth of proton experience
Insights from the 6th International Symposium on Focused Ultrasound
Began treatment on average 35 days after diagnosis, compared to 49.6 days for those in standard care
Patients reluctantly in the dark when it comes to understanding imaging
Measuring appropriate use and untapped potential with two new studies
A comparison of conventional radiation therapy and next-generation radiosurgery.
ASTRO applauds
Could lead to genetic screenings to identify humans who should not be imaged with radiation
Market analysis from the experts at symplr
Replacement for heavy lead aprons
Scott Warwick was chosen for the role following a nationwide search
